Apoptosis
Apoptosis(凋亡)
As one of the cellular death mechanisms, apoptosis, also known as programmed cell death, can be defined as the process of a proper death of any cell under certain or necessary conditions. Apoptosis is controlled by the interactions between several molecules and responsible for the elimination of unwanted cells from the body.
Many biochemical events and a series of morphological changes occur at the early stage and increasingly continue till the end of apoptosis process. Morphological event cascade including cytoplasmic filament aggregation, nuclear condensation, cellular fragmentation, and plasma membrane blebbing finally results in the formation of apoptotic bodies. Several biochemical changes such as protein modifications/degradations, DNA and chromatin deteriorations, and synthesis of cell surface markers form morphological process during apoptosis.
Apoptosis can be stimulated by two different pathways: (1) intrinsic pathway (or mitochondria pathway) that mainly occurs via release of cytochrome c from the mitochondria and (2) extrinsic pathway when Fas death receptor is activated by a signal coming from the outside of the cell.
Different gene families such as caspases, inhibitor of apoptosis proteins, B cell lymphoma (Bcl)-2 family, tumor necrosis factor (TNF) receptor gene superfamily, or p53 gene are involved and/or collaborate in the process of apoptosis.
Caspase family comprises conserved cysteine aspartic-specific proteases, and members of caspase family are considerably crucial in the regulation of apoptosis. There are 14 different caspases in mammals, and they are basically classified as the initiators including caspase-2, -8, -9, and -10; and the effectors including caspase-3, -6, -7, and -14; and also the cytokine activators including caspase-1, -4, -5, -11, -12, and -13. In vertebrates, caspase-dependent apoptosis occurs through two main interconnected pathways which are intrinsic and extrinsic pathways. The intrinsic or mitochondrial apoptosis pathway can be activated through various cellular stresses that lead to cytochrome c release from the mitochondria and the formation of the apoptosome, comprised of APAF1, cytochrome c, ATP, and caspase-9, resulting in the activation of caspase-9. Active caspase-9 then initiates apoptosis by cleaving and thereby activating executioner caspases. The extrinsic apoptosis pathway is activated through the binding of a ligand to a death receptor, which in turn leads, with the help of the adapter proteins (FADD/TRADD), to recruitment, dimerization, and activation of caspase-8 (or 10). Active caspase-8 (or 10) then either initiates apoptosis directly by cleaving and thereby activating executioner caspase (-3, -6, -7), or activates the intrinsic apoptotic pathway through cleavage of BID to induce efficient cell death. In a heat shock-induced death, caspase-2 induces apoptosis via cleavage of Bid.
Bcl-2 family members are divided into three subfamilies including (i) pro-survival subfamily members (Bcl-2, Bcl-xl, Bcl-W, MCL1, and BFL1/A1), (ii) BH3-only subfamily members (Bad, Bim, Noxa, and Puma9), and (iii) pro-apoptotic mediator subfamily members (Bax and Bak). Following activation of the intrinsic pathway by cellular stress, pro‑apoptotic BCL‑2 homology 3 (BH3)‑only proteins inhibit the anti‑apoptotic proteins Bcl‑2, Bcl-xl, Bcl‑W and MCL1. The subsequent activation and oligomerization of the Bak and Bax result in mitochondrial outer membrane permeabilization (MOMP). This results in the release of cytochrome c and SMAC from the mitochondria. Cytochrome c forms a complex with caspase-9 and APAF1, which leads to the activation of caspase-9. Caspase-9 then activates caspase-3 and caspase-7, resulting in cell death. Inhibition of this process by anti‑apoptotic Bcl‑2 proteins occurs via sequestration of pro‑apoptotic proteins through binding to their BH3 motifs.
One of the most important ways of triggering apoptosis is mediated through death receptors (DRs), which are classified in TNF superfamily. There exist six DRs: DR1 (also called TNFR1); DR2 (also called Fas); DR3, to which VEGI binds; DR4 and DR5, to which TRAIL binds; and DR6, no ligand has yet been identified that binds to DR6. The induction of apoptosis by TNF ligands is initiated by binding to their specific DRs, such as TNFα/TNFR1, FasL /Fas (CD95, DR2), TRAIL (Apo2L)/DR4 (TRAIL-R1) or DR5 (TRAIL-R2). When TNF-α binds to TNFR1, it recruits a protein called TNFR-associated death domain (TRADD) through its death domain (DD). TRADD then recruits a protein called Fas-associated protein with death domain (FADD), which then sequentially activates caspase-8 and caspase-3, and thus apoptosis. Alternatively, TNF-α can activate mitochondria to sequentially release ROS, cytochrome c, and Bax, leading to activation of caspase-9 and caspase-3 and thus apoptosis. Some of the miRNAs can inhibit apoptosis by targeting the death-receptor pathway including miR-21, miR-24, and miR-200c.
p53 has the ability to activate intrinsic and extrinsic pathways of apoptosis by inducing transcription of several proteins like Puma, Bid, Bax, TRAIL-R2, and CD95.
Some inhibitors of apoptosis proteins (IAPs) can inhibit apoptosis indirectly (such as cIAP1/BIRC2, cIAP2/BIRC3) or inhibit caspase directly, such as XIAP/BIRC4 (inhibits caspase-3, -7, -9), and Bruce/BIRC6 (inhibits caspase-3, -6, -7, -8, -9).
Any alterations or abnormalities occurring in apoptotic processes contribute to development of human diseases and malignancies especially cancer.
References:
1.Yağmur Kiraz, Aysun Adan, Melis Kartal Yandim, et al. Major apoptotic mechanisms and genes involved in apoptosis[J]. Tumor Biology, 2016, 37(7):8471.
2.Aggarwal B B, Gupta S C, Kim J H. Historical perspectives on tumor necrosis factor and its superfamily: 25 years later, a golden journey.[J]. Blood, 2012, 119(3):651.
3.Ashkenazi A, Fairbrother W J, Leverson J D, et al. From basic apoptosis discoveries to advanced selective BCL-2 family inhibitors[J]. Nature Reviews Drug Discovery, 2017.
4.McIlwain D R, Berger T, Mak T W. Caspase functions in cell death and disease[J]. Cold Spring Harbor perspectives in biology, 2013, 5(4): a008656.
5.Ola M S, Nawaz M, Ahsan H. Role of Bcl-2 family proteins and caspases in the regulation of apoptosis[J]. Molecular and cellular biochemistry, 2011, 351(1-2): 41-58.
- Caspase(102)
- 14.3.3 Proteins(2)
- Apoptosis Inducers(45)
- Bax(7)
- Bcl-2 Family(122)
- Bcl-xL(8)
- c-RET(9)
- IAP(27)
- KEAP1-Nrf2(67)
- MDM2(15)
- p53(128)
- PC-PLC(5)
- PKD(8)
- RasGAP (Ras- P21)(1)
- Survivin(8)
- Thymidylate Synthase(10)
- TNF-α(151)
- Other Apoptosis(900)
- Apoptosis Detection
- Caspase Substrate
- APC(6)
- PD-1/PD-L1 interaction(91)
- ASK1(3)
- PAR4(2)
- RIP kinase(52)
- FKBP(20)
- Pyroptosis(32)
Apoptosis 相关产品(2721)
- GN10249Polyphyllin VICAS: 55916-51-3纯度: >98.00%
Polyphyllin VI是一种具有口服活性的天然皂苷,主要通过诱导细胞周期阻滞、细胞凋亡和细胞焦亡发挥抗癌作用。
- GN10254Ginsenoside RcCAS: 11021-14-0纯度: >98.00% / >99.50%
A saponin with diverse biological activities
- GN10275Protosappanin BCAS: 102036-29-3纯度: >99.00%
Protosappanin B 是一种从 Lignum Sappan 中提取的酚类化合物。抗癌活性。 Protosappanin B 在人膀胱癌细胞中诱导细胞凋亡并导致 G1 细胞周期停滞。
- GN10341Acetate gossypolCAS: 12542-36-8纯度: >99.00%
Acetate gossypol是一种从棉花植株中提取的脂溶性多酚类化合物,具有抗生育、抗氧化和抗癌特性。
- GN10357ParthenolideCAS: 20554-84-1纯度: >99.50% / >97.00%
Parthenolide是一种NF-κB抑制剂,对Eca109、KYSE-510、SiHa和MCF-7细胞48h的IC 50 值分别约为10.3、13.3、8.42和9.54µM。
- GN10358Berbamine hydrochlorideCAS: 6078-17-7
A bisbenzylisoquinoline alkaloid with diverse biological activities
- GN10361Pseudolaric Acid BCAS: 82508-31-4纯度: >98.00%
Compound from Chinese traditional medicine with reported antifungal, anticancer actions
- GN10394Atractylenolide IIICAS: 73030-71-4纯度: >98.00%
A sesquiterpene with diverse biological activities
| 货号 | 产品名称 | CAS号 | 纯度 | 结构 |
|---|---|---|---|---|
| GN10219 | Ciwujianoside-B | 114902-16-8 | - | |
Ciwujianoside-B 是从刺五加叶中分离得到的,口服后能在大脑中渗透和发挥作用。 | ||||
| GN10248 | Hesperitin | 520-33-2 | >98.50% | |
A hypocholesterolemic citrus flavonoid | ||||
| GN10249 | Polyphyllin VI | 55916-51-3 | >98.00% | |
Polyphyllin VI是一种具有口服活性的天然皂苷,主要通过诱导细胞周期阻滞、细胞凋亡和细胞焦亡发挥抗癌作用。 | ||||
| GN10254 | Ginsenoside Rc | 11021-14-0 | >98.00% / >99.50% | |
A saponin with diverse biological activities | ||||
| GN10269 | Wedelolactone | 524-12-9 | >99.50% | |
A natural NF-κB inhibitor | ||||
| GN10275 | Protosappanin B | 102036-29-3 | >99.00% | |
Protosappanin B 是一种从 Lignum Sappan 中提取的酚类化合物。抗癌活性。 Protosappanin B 在人膀胱癌细胞中诱导细胞凋亡并导致 G1 细胞周期停滞。 | ||||
| GN10280 | Sinensetin | 2306-27-6 | >99.50% / >98.00% | |
An anti-inflammatory flavone | ||||
| GN10284 | Dioscin | 19057-60-4 | >98.00% | |
A natural steroid saponin | ||||
| GN10302 | Hypericin | 548-04-9 | >98.00% | |
An anthroquinone derivative | ||||
| GN10318 | Danshensu | 22681-72-7 | >98.00% | |
A salvianolic acid with diverse biological activities | ||||
| GN10321 | Glycitein | 40957-83-3 | >98.00% | |
A major isoflavone | ||||
| GN10325 | Nobiletin | 478-01-3 | >99.00% | |
Nobiletin是从柑橘类植物中提取的一种多甲氧基黄酮类化合物。Nobiletin具有抗氧化、抗炎、抗肿瘤等多种药理作用。 | ||||
| GN10331 | Polydatin | 27208-80-6 | >98.50% / >98.00% | |
Polydatin是从传统中药Polygonum cuspidatum中提取的一种天然二苯乙烯类葡萄糖苷,是白藜芦醇的糖苷形式。 | ||||
| GN10333 | Osthole | 484-12-8 | >99.50% | |
A coumarin with diverse biological activities | ||||
| GN10335 | Mesaconitine | 2752-64-9 | >98.50% | |
新乌头碱是乌头属植物的主要活性成分。 | ||||
| GN10341 | Acetate gossypol | 12542-36-8 | >99.00% | |
Acetate gossypol是一种从棉花植株中提取的脂溶性多酚类化合物,具有抗生育、抗氧化和抗癌特性。 | ||||
| GN10357 | Parthenolide | 20554-84-1 | >99.50% / >97.00% | |
Parthenolide是一种NF-κB抑制剂,对Eca109、KYSE-510、SiHa和MCF-7细胞48h的IC 50 值分别约为10.3、13.3、8.42和9.54µM。 | ||||
| GN10358 | Berbamine hydrochloride | 6078-17-7 | - | |
A bisbenzylisoquinoline alkaloid with diverse biological activities | ||||
| GN10360 | Morroniside | 25406-64-8 | >98.00% | |
A mixture of iridoid glucosides | ||||
| GN10361 | Pseudolaric Acid B | 82508-31-4 | >98.00% | |
Compound from Chinese traditional medicine with reported antifungal, anticancer actions | ||||
| GN10370 | Luteolin | 491-70-3 | >98.00% | |
木犀草素(Luteolin)是一种黄酮类化合物,具有抗炎、抗氧化、抗癌等多种功能。Luteolin是一种有效的核因子红细胞2相关因子2(Nrf2)抑制剂。 | ||||
| GN10388 | Gallic acid | 149-91-7 | >99.50% / >99.00% | |
A phenol with diverse biological activities | ||||
| GN10394 | Atractylenolide III | 73030-71-4 | >98.00% | |
A sesquiterpene with diverse biological activities | ||||
| GN10405 | Loganin | 18524-94-2 | >98.00% | |
An iridoid glycoside with diverse biological activities | ||||
